Touchstone
Last syncOct 31, 2026, 6:54 PM ET

PNTG

Pennant Group, Inc. Health Care Services-Health Services Russell 3000
$41.66Close $1.4BMarket cap $23.75 – $42.5752-week range Nov 4, 2026Next report
Stage 2 Leader 58th of 68Contraction Setup 3rd of 8

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 87 · stronger than 87% of stocks over 12 months
  • Near its high 2% below its 52-week high
  • Tight base near its pivot pullbacks 10% → 9% → 5%; 2.3% below its $42.66 pivot
  • Earnings growing EPS +26% year on year, faster than the quarter before (+18 pts)

Cautions

  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 5, 2026
Off 12-month high 2%
1wk down 0.5% price change
1mo up 6.8% price change
12-month return up 69% market up 11% · its own up 56%
F-score — — Not assessed
Altman Z″ 1.45 Moderate risk
P/E 48.8× price / earnings
PEG 2.59 P/E / EPS growth
P/B 3.9× price / book
Earnings yield up 3.3% EBIT / enterprise value
Cheaper than 44% of the market · around average
Revenue growth up 36% year on year
EPS growth up 26% latest quarter · +18 pts
Sales growth up 36% latest quarter · -0 pts
ROE up 9% return on equity
Free cash margin up 4% $36.3M FCF
D/E 0.45 long-term debt / equity
Net debt / EBITDA 2.5×
Interest cover —EBIT / interest

Trade setup

ATR% 3.2% $1.33 a day · 2×ATR $39.01
RS 87 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.1× vs 50-day average
Up/down volume 0.83 50 sessions
Implied move — no option chain · report Nov 4, 2026
Contractions 3 10% → 9% → 5%
Pivot $42.66 2.3% below
Volume dry-up 0.9× 10 vs 50 sessions
Trend template · 8 of 8

Screen verdict

2 of 3 screens
  • Stage 2 Leader in mixed conditions
    • RS 87
    • Trend 8/8
    • Off 12-month high 2%
    • EPS growth +26% (accel +18 pts)
    • Sales growth +36% (accel -0 pts)
    • Altman Z″ 1.45 (moderate risk)
  • Contraction Setup in mixed conditions
    • RS 87
    • Trend 8/8
    • 3 contractions (10% → 9% → 5%)
    • 2.3% below pivot 42.66
    • Volume at 92% of its 50d average
    • EPS growth +26% (accel +18 pts)

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 5, 2026
Results reaction Aug 5, 2026+2% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $947.7M +36% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $391.0M FY2021 · $439.7M FY2022 · $473.2M FY2023 · $544.9M FY2024 · $695.2M FY2025 · $947.7M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $29.6M +31% on FY2024
$0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $15.7M FY2021 · $2.7M FY2022 · $6.6M FY2023 · $13.4M FY2024 · $22.6M FY2025 · $29.6M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $36.3M +20% on FY2024
-$25M $0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $43.0M FY2021 · -$24.5M FY2022 · -$5.1M FY2023 · $25.0M FY2024 · $30.3M FY2025 · $36.3M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 3%
  • Free cash 4%
-10% 0% 20% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 4% · Free cash 11% FY2021 · Net 1% · Free cash -6% FY2022 · Net 1% · Free cash -1% FY2023 · Net 2% · Free cash 5% FY2024 · Net 3% · Free cash 4% FY2025 · Net 3% · Free cash 4%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $151.8M net debt
  • Cash
  • Long-term debt
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $43,000 · Long-term debt $8.3M FY2021 · Cash $5.2M · Long-term debt $51.4M FY2022 · Cash $2.1M · Long-term debt $62.9M FY2023 · Cash $6.1M · Long-term debt $63.9M FY2024 · Cash $24.2M · Long-term debt $0 FY2025 · Cash $17.0M · Long-term debt $168.8M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 34.63m +22.6% since FY2020
34.63m 28.24m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 28.24m FY2021 · 28.50m FY2022 · 29.69m FY2023 · 29.95m FY2024 · 34.37m FY2025 · 34.63m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $391.0M $439.7M $473.2M $544.9M $695.2M $947.7M
Operating income $18.9M $4.7M $12.7M $25.2M $38.1M $51.9M
Net income $15.7M $2.7M $6.6M $13.4M $22.6M $29.6M
Net margin 4% 1% 1% 2% 3% 3%
Earnings per share $0.52 $0.09 $0.22 $0.44 $0.70 $0.84
Free cash flow $43.0M -$24.5M -$5.1M $25.0M $30.3M $36.3M
Free cash margin 11% -6% -1% 5% 4% 4%
Cash $43,000 $5.2M $2.1M $6.1M $24.2M $17.0M
Long-term debt $8.3M $51.4M $62.9M $63.9M $0 $168.8M
Shareholders' equity $101.2M $114.2M $125.7M $145.5M $312.0M $374.3M
Shares outstanding 28.24m 28.50m 29.69m 29.95m 34.37m 34.63m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jun 30, 2026 36d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 5, 2025 Quarterly ↗ Sep 30, 2025 36d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 6, 2025 Quarterly ↗ Mar 31, 2025 36d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 6, 2024 Quarterly ↗ Sep 30, 2024 37d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 6, 2024 Quarterly ↗ Mar 31, 2024 36d
Feb 28, 2024 Annual ↗ Dec 31, 2023 59d
Nov 7, 2023 Quarterly ↗ Sep 30, 2023 38d

Current reports

FiledDisclosed
Aug 5, 2026 Results · Regulation FD ↗
May 20, 2026 Shareholder vote ↗
May 6, 2026 Results · Regulation FD ↗
Feb 25, 2026 Results · Regulation FD ↗
Nov 5, 2025 Material agreement · New obligation ↗
Nov 5, 2025 Results · Regulation FD ↗
Oct 2, 2025 Material agreement ↗
Oct 2, 2025 Acquisition or disposal · Regulation FD ↗
Aug 6, 2025 Results · Regulation FD ↗
May 20, 2025 Shareholder vote ↗
May 6, 2025 Results · Regulation FD ↗
May 1, 2025 Material agreement ↗